Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Melliderm
AddedMar 20, 2024
UpdatedJun 18, 2026
Melliderm

Melliderm

Manufacturing skincare for diabetics in NYC. Helping 24M+ diabetics & 79M+ pre-diabetics. Promoting healing & preventing infections.

HQ
New York City, NY, US
Founded
2014
Overview
Compare
Fundraising
Employees

MelliDerm Inc. is a Skyler Brand Ventures company poised to fill the void in the diabetes skincare market, introducing truly efficacious skincare products for the more than 24 million diabetic people in the US. A secondary market also consists of the 79 million pre-diabetic people in the country who may experience some variation of the symptoms.

The company aims to produce and market a skincare system that actually helps diabetic skin regain some of the key characteristics of normal skin, rather than merely masking the dry, itchy symptoms. It will help maintain normal skin flora, prevent infections and promote healing.

Melliderm - Similar Companies

DermApproved logo

DermApproved

dermapproved.com

Lavior logo

Lavior

lavior.com

Dermala logo

Dermala

dermala.com

FutureDerm logo

FutureDerm

Soteri Skin logo

Soteri Skin

soteriskin.com

Dermamedics logo

Dermamedics

dermamedics.com

Microdermis logo

Microdermis

Dermarus logo

Dermarus

Sciote Skin logo

Sciote Skin

Dermaliq Therapeutics logo

Dermaliq Therapeutics

dermaliq.com

Dermal Life logo

Dermal Life

Skin Pharm logo

Skin Pharm

skinpharm.com

Crescel logo

Crescel

Stratia logo

Stratia

stratiaskin.com

CureSkin logo

CureSkin

cureskin.com

Melliderm - Quick Facts

Who are Melliderm's competitors?

Companies similar to Melliderm include DermApproved, Lavior, Dermala and FutureDerm.

When was Melliderm founded?

Melliderm was founded in 2014.

Where is Melliderm's headquarters located?

Melliderm's headquarters is located in New York City, NY, US.

When was Melliderm's last funding round?

Melliderm's most recent funding round was for $900k (USD) in January 2017.

How much has Melliderm raised to-date?

As of Jan 24, 2017, Melliderm has raised a total of $900k (USD).

How many employees does Melliderm have?

Melliderm has 5 employees as of Feb 5, 2024.

Melliderm - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Cosmetics
  • Skincare
Tags
  • eCommerce
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325600Soap, Cleaning Compound, and Toilet Preparation Manufacturing
  • 325620Toilet Preparation Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2844Perfumes, Cosmetics, And Other Toilet Preparations
  • 2800Chemicals And Allied Products
Show 2 more industry codes
NAICS
  • 330000Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries